TRENDS IN APPROVAL OF THERAPEUTIC BIOLOGIC APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (1986-2017)

被引：0
|
作者：
Kim, J. [1 ]
Min, E. [1 ]
Nishikawa, K. [1 ]
Patel, P. [1 ]
Rouzitalab, L. [1 ]
Tomaszewski, D. M. [1 ]
Seoane-Vazquez, E. [1 ]
机构：
[1] Chapman Univ, Irvine, CA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.631
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP40
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] TRENDS IN APPROVAL OF ADVANCED THERAPY MEDICINAL PRODUCTS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION
    Alsheikh, M. Y.
    Shukla, V
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2018, 21 : S261 - S261
  • [2] PRICE ANALYSIS OF THERAPEUTIC BIOLOGICS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (1986-OCTOBER 2015)
    Turkistani, F.
    Alotaibi, A.
    Alnafesah, A.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2016, 19 (03) : A271 - A272
  • [3] Main Trends in US Inbound and Outbound Direct Investment in Insurance in 1986-2017
    Nebolsina, Elena V.
    VISION 2020: SUSTAINABLE ECONOMIC DEVELOPMENT AND APPLICATION OF INNOVATION MANAGEMENT, 2018, : 2056 - 2064
  • [4] Scientific Evidence Supporting Benefits of Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2017
    Heyward, James
    Alexander, G. Caleb
    Moore, Thomas J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 7 - 8
  • [5] Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017
    Zhang, Audrey D.
    Puthumana, Jeremy
    Downing, Nicholas S.
    Shah, Nilay D.
    Krumholz, Harlan M.
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2020, 3 (04)
  • [6] US Food and Drug Administration and Design of Drug Approval Studies
    Woloshin, Steven
    Schwartz, Lisa M.
    Frankel, Brittney
    Faerber, Adrienne
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
  • [7] US Food and Drug Administration approval of esketamine and brexanolone
    Cristea, Ioana A.
    Naudet, Florian
    LANCET PSYCHIATRY, 2019, 6 (12): : 975 - 977
  • [8] Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug Administration
    Berman, Julia
    Yavne, Yarden
    Edel, Yonatan
    Elkayam, Ori
    Furer, Victoria
    Shepshelovich, Daniel
    MAYO CLINIC PROCEEDINGS, 2022, 97 (08) : 1512 - 1522
  • [9] Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
    Sachs, Rachel E.
    Gavulic, Kyle A.
    Donohue, Julie M.
    Dusetzina, Stacie B.
    JAMA HEALTH FORUM, 2021, 2 (10): : E213177
  • [10] Trends in amorphous solid dispersion drug products approved by the US Food and Drug Administration between 2012 and 2023
    Moseson, Dana E.
    Tran, Trong Bien
    Karunakaran, Bharathi
    Ambardekar, Rohan
    Hiew, Tze Ning
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2024, 7
12345